ZA200805052B - Use of anecortave acetate as an adjunct during filtration bleb surgery - Google Patents

Use of anecortave acetate as an adjunct during filtration bleb surgery

Info

Publication number
ZA200805052B
ZA200805052B ZA200805052A ZA200805052A ZA200805052B ZA 200805052 B ZA200805052 B ZA 200805052B ZA 200805052 A ZA200805052 A ZA 200805052A ZA 200805052 A ZA200805052 A ZA 200805052A ZA 200805052 B ZA200805052 B ZA 200805052B
Authority
ZA
South Africa
Prior art keywords
during filtration
anecortave acetate
filtration bleb
surgery
adjunct during
Prior art date
Application number
ZA200805052A
Other languages
English (en)
Inventor
Alan L Robin
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of ZA200805052B publication Critical patent/ZA200805052B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
ZA200805052A 2005-12-23 2006-12-22 Use of anecortave acetate as an adjunct during filtration bleb surgery ZA200805052B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75351105P 2005-12-23 2005-12-23

Publications (1)

Publication Number Publication Date
ZA200805052B true ZA200805052B (en) 2009-10-28

Family

ID=38067101

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200805052A ZA200805052B (en) 2005-12-23 2006-12-22 Use of anecortave acetate as an adjunct during filtration bleb surgery

Country Status (9)

Country Link
EP (1) EP1962857A2 (ko)
JP (1) JP2009521511A (ko)
KR (1) KR20080078042A (ko)
CN (1) CN101346145A (ko)
AU (1) AU2006330531A1 (ko)
BR (1) BRPI0620411A2 (ko)
CA (1) CA2631838A1 (ko)
WO (1) WO2007076467A2 (ko)
ZA (1) ZA200805052B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080125406A1 (en) * 2005-10-14 2008-05-29 Robin Alan L Method for Treating Primary and Secondary Forms of Glaucoma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798356A (en) * 1995-08-07 1998-08-25 Alcon Laboratories, Inc. Angiostatic compounds
WO1997041867A1 (en) * 1996-05-09 1997-11-13 Alcon Laboratories, Inc. Use of steroid compounds to prevent non-cancerous tissue growth
US6011023A (en) * 1997-08-27 2000-01-04 Alcon Laboratories, Inc. Angiostatic steroids
US6489305B1 (en) * 1998-05-08 2002-12-03 Canji, Inc. Methods and compositions for the treatment of ocular diseases
US20050239760A1 (en) * 2004-04-23 2005-10-27 Alcon, Inc. Angiostatic agents and methods and compositions for controlling ocular hypertension

Also Published As

Publication number Publication date
EP1962857A2 (en) 2008-09-03
WO2007076467A3 (en) 2007-08-16
BRPI0620411A2 (pt) 2011-11-08
WO2007076467A2 (en) 2007-07-05
CA2631838A1 (en) 2007-07-05
CN101346145A (zh) 2009-01-14
AU2006330531A1 (en) 2007-07-05
KR20080078042A (ko) 2008-08-26
JP2009521511A (ja) 2009-06-04

Similar Documents

Publication Publication Date Title
EP1638508A4 (en) SHUNT FOR GLUCKOM TREATMENT
EG24420A (en) Treatment of ophthalmic conditions
PL2335782T3 (pl) Zastosowanie kompozycji zawierającej HFCO-1233zd
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
IL190885A0 (en) Immunogenic compositions and methods of use
EP1893216A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
IL182010A0 (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases
ZA200710342B (en) The preparation and use of compounds as aspartyl protease inhibitors
EP1789086A4 (en) PROLONGED TREATMENT OF MULTIPLE SCLEROSIS
EP1951278A4 (en) METHODS AND COMPOSITIONS FOR DEREPRESSION OF IPA-INHIBITED CASPASE
TWI367257B (en) Process for the preparation of 2-butanol
IL189364A0 (en) Estrogen compositions and therapeutic methods of use thereof
IL174627A0 (en) Compositions and methods for treatment of burns
IL190779A0 (en) Compositions for treatment of eye diseases
PL1778621T3 (pl) Wytwarzanie jodiksanolu
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
PT2380573E (pt) Acetato de eslicarbazepina e métodos de utilização
EP1931385A4 (en) (S) -6-METHYLOXAALKYL EXEMESTANE COMPOUNDS AND METHODS OF USE
EP1928252A4 (en) PIGGY COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE
GB0509720D0 (en) Configuration of VPNs
EP1689309A4 (en) RETRACTABLE EYE CLOTH
IL188787A (en) Preparations for the treatment of diabetic eye complications
ZA200704775B (en) Compositions for treatment of ear infections
GB0400976D0 (en) Methods of diagnosis
ZA200805052B (en) Use of anecortave acetate as an adjunct during filtration bleb surgery